Luo, Kewang. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2013. / Includes bibliographical references (leaves 278-305). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

Cheng, Baohui. / Thesis (Ph.D.)--Chinese University of Hong Kong, 2013. / Includes bibliographical references (leaves 206-221). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstracts also in Chinese.

Chan Chak Ming. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (leaves 178-202). / Abstracts in English and Chinese. / Abstract --- p.i / Abstract in Chinese 摘耍 --- p.iii / Acknowledgements --- p.v / Table of contents --- p.vi / List of tables --- p.xii / List of figures --- p.xiii / Abbreviations --- p.xvi / Chapter Chapter 1: --- Introduction --- p.1 / Chapter 1.1 --- Definition of diabetes mellitus --- p.1 / Chapter 1.2 --- Classification of diabetes mellitus --- p.4 / Chapter 1.2.1 --- Type 1 diabetes --- p.4 / Chapter 1.2.2 --- Type 2 diabetes --- p.5 / Chapter 1.2.3 --- Other forms of diabetes --- p.9 / Chapter 1.3 --- Complications of diabetes mellitus --- p.11 / Chapter 1.4 --- Current treatment of diabetes mellitus --- p.12 / Chapter 1.4.1 --- Type 1 diabetes --- p.12 / Chapter 1.4.2 --- Type 2 diabetes --- p.13 / Chapter 1.4.2.1 --- Diet and exercise --- p.13 / Chapter 1.4.2.2 --- Medication --- p.13 / Chapter 1.5 --- The use of herbal medicines in diabetes treatment --- p.18 / Chapter 1.6 --- "Hypothesis, objectives and design of the project" --- p.22 / Chapter Chapter 2: --- Preparation and authentication of traditional Chinese medicines --- p.23 / Chapter 2.1 --- Introduction --- p.23 / Chapter 2.1.1 --- Background information of the formulae --- p.23 / Chapter 2.1.2 --- Component herbs of formula1 --- p.26 / Chapter 2.2 --- Objectives --- p.29 / Chapter 2.3 --- Materials --- p.30 / Chapter 2.3.1 --- Raw herbal materials and formula 1 extract --- p.30 / Chapter 2.3.2 --- Thin layer chromatography --- p.35 / Chapter 2.3.3 --- High performance liquid chromatography determination of the sugar content of the herbal extracts --- p.38 / Chapter 2.4 --- Methods --- p.41 / Chapter 2.4.1 --- Thin layer chromatography of the component herbs --- p.41 / Chapter 2.4.2 --- Raw herbal materials water extraction --- p.46 / Chapter 2.4.3 --- High performance liquid chromatography determination of the sugar content of the herbal extracts --- p.46 / Chapter 2.5 --- Results --- p.49 / Chapter 2.5.1 --- Thin layer chromatography of the component herbs --- p.49 / Chapter 2.5.2 --- Raw herbal materials water extraction --- p.56 / Chapter 2.5.3 --- High performance liquid chromatography determination of the sugar content of the herbal extracts --- p.57 / Chapter 2.6 --- Discussion --- p.62 / Chapter Chapter 3: --- The anti-diabetic effects of formula 1 and its component herbs in vitro --- p.67 / Chapter 3.1 --- Introduction --- p.67 / Chapter 3.1.1 --- Glycaemic control in type 2 diabetes --- p.67 / Chapter 3.1.2 --- Type 2 diabetes and peripheral tissues --- p.70 / Chapter 3.1.3 --- Type 2 diabetes and liver --- p.73 / Chapter 3.1.4 --- Type 2 diabetes and intestinal glucose absorption --- p.76 / Chapter 3.2 --- Objectives --- p.79 / Chapter 3.3 --- Materials --- p.80 / Chapter 3.3.1 --- Cell lines --- p.80 / Chapter 3.3.2 --- "Cell culture media, buffers, reagents and culture wares" --- p.81 / Chapter 3.3.3 --- "Chemicals, media and reagents for 3T3-L1 differentiation" --- p.83 / Chapter 3.3.4 --- Chemicals and reagents for 3T3-L1 and Hs68 2-deoxy-D- glucose (2-DG) uptake assay --- p.84 / Chapter 3.3.5 --- Chemicals and buffers for H4IIE glucose production assay and phosphoenolpyruvate carboxykinase (PEPCK) assay --- p.85 / Chapter 3.3.6 --- "Animal, buffers and reagents for preparation and glucose uptake assay of brush border membrane vesicles (BBMV)" --- p.87 / Chapter 3.3.7 --- Reagents for bicinchoninic acid (BCA) protein assay --- p.88 / Chapter 3.4 --- Methods --- p.89 / Chapter 3.4.1 --- Cell culture --- p.89 / Chapter 3.4.2 --- Studies on glucose uptake in 3T3-L1 adipocytes and Hs68 fibroblasts --- p.90 / Chapter 3.4.2.1 --- Differentiation of 3T3-L1 cells --- p.90 / Chapter 3.4.2.2 --- Oil red O staining of the 3T3-L1 cells --- p.90 / Chapter 3.4.2.3 --- 2-DG uptake assay of 3T3-L1 adipocytes and Hs68 fibroblasts --- p.91 / Chapter 3.4.3 --- Studies on gluconeogenesis in H4IIE hepatoma cells --- p.93 / Chapter 3.4.3.1 --- Glucose production assay --- p.93 / Chapter 3.4.3.2 --- PEPCK assay --- p.94 / Chapter 3.4.4 --- Studies on BBMV glucose uptake --- p.95 / Chapter 3.4.4.1 --- Preparation of BBMV --- p.95 / Chapter 3.4.4.2 --- Preparation of the chloroform extract of the herbal water extract --- p.96 / Chapter 3.4.4.3 --- Glucose uptake assay of BBMV --- p.97 / Chapter 3.4.5 --- BCA (Bicinchoninic acid) protein assay --- p.99 / Chapter 3.4.6 --- Statistical analysis --- p.100 / Chapter 3.5 --- Results --- p.101 / Chapter 3.5.1 --- Glucose uptake assay in 3T3-L1 adipocytes and Hs68 fibroblasts --- p.101 / Chapter 3.5.2 --- Glucose production and PEPCK assay in H4IIE hepatoma cells --- p.108 / Chapter 3.5.3 --- Glucose uptake assay in BBMV --- p.113 / Chapter 3.6 --- Discussion --- p.119 / Chapter 3.6.1 --- Glucose uptake in 3T3-L1 adipocytes and Hs68 fibroblasts --- p.119 / Chapter 3.6.2 --- Glucose production and PEPCK activity in H4IIE hepatoma cells --- p.123 / Chapter 3.6.3 --- Glucose absorption in BBMV --- p.125 / Chapter 3.6.4 --- Conclusion --- p.128 / Chapter Chapter 4: --- The anti-diabetic effects of formula 1 and Rhizoma Smilacis Chinensis in vivo --- p.131 / Chapter 4.1 --- Introduction --- p.131 / Chapter 4.1.1 --- Diabetic animal models --- p.131 / Chapter 4.1.2 --- Neonatal streptozotocin-induced diabetic rat model --- p.133 / Chapter 4.2 --- Objective --- p.136 / Chapter 4.3 --- Materials --- p.137 / Chapter 4.3.1 --- Animals --- p.137 / Chapter 4.3.2 --- Chemicals and reagent kit --- p.137 / Chapter 4.4 --- Methods --- p.139 / Chapter 4.4.1 --- Induction of diabetes in rats --- p.139 / Chapter 4.4.2 --- Oral glucose tolerance test --- p.139 / Chapter 4.4.3 --- Basal glycaemia test --- p.141 / Chapter 4.4.4 --- Plasma glucose level determination --- p.142 / Chapter 4.4.5 --- Statistical analysis --- p.142 / Chapter 4.5 --- Results --- p.143 / Chapter 4.5.1 --- Oral glucose tolerance test --- p.143 / Chapter 4.5.2 --- Basal glycaemia test --- p.147 / Chapter 4.6 --- Discussion --- p.151 / Chapter Chapter 5: --- The effects of the TCM treatment on glucose homeostasis in diabetic foot ulcer patients --- p.155 / Chapter 5.1 --- Introduction --- p.155 / Chapter 5.2 --- Objective --- p.156 / Chapter 5.3 --- Materials --- p.157 / Chapter 5.3.1 --- Study subjects --- p.157 / Chapter 5.3.2 --- Blood sample --- p.158 / Chapter 5.3.3 --- Chemicals and reagents for erythrocyte glucose uptake assay --- p.158 / Chapter 5.4 --- Methods --- p.160 / Chapter 5.4.1 --- Preparation of blood sample --- p.160 / Chapter 5.4.2 --- Zero-trans influx of 3-OMG uptake in erythrocytes --- p.160 / Chapter 5.4.3 --- Statistical analysis --- p.161 / Chapter 5.5 --- Results --- p.162 / Chapter 5.6 --- Discussion --- p.166 / Chapter Chapter 6: --- General discussion and conclusion --- p.168 / Chapter 6.1 --- Overview of the project and analysis of research findings --- p.168 / Chapter 6.2 --- Limitations of the study --- p.173 / Chapter 6.3 --- Future directions --- p.174 / Chapter 6.4 --- Conclusion --- p.177 / Chapter Chapter 7: --- References --- p.177 / Appendices --- p.203 / Appendix I The determination of the sugar contents in the herbal water extracts by high performance liquid chromatography --- p.203 / Appendix II Basal glycaemia test of formula 1 (822mg/kg) on nO-STZ rats --- p.206

Yeung Ming. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2003. / Includes bibliographical references (leaves 136-162). / Abstracts in English and Chinese. / THESIS COMMITTEE --- p.i / ACKNOWLEDGEMENTS --- p.ii / ABSTRACT (ENGLISH) --- p.iii~v / ABSTRACT (CHINESE) --- p.vi~vii / TABLE OF CONTENTS --- p.viii~xiii / LIST OF TABLES --- p.xiv~xv / LIST OF FIGURES --- p.xvi~xviii / LIST OF ABBREVIATIONS --- p.xix~xx / Chapter CHAPTER ONE: --- INTRODUCTION --- p.1 / Chapter 1.1 --- Different lipoproteins and their functions --- p.1 / Chapter 1.1.1 --- Chylomicrons --- p.4 / Chapter 1.1.2 --- VLDL --- p.4 / Chapter 1.1.3 --- LDL --- p.4 / Chapter 1.1.4 --- HDL --- p.5 / Chapter 1.2 --- Risk factors of coronary heart disease (CHD) --- p.5 / Chapter 1.2.1 --- Background information of CHD --- p.6 / Chapter 1.2.2 --- "Relationship between serum total cholesterol (TC), Low-density lipoprotein (LDL) cholesterol and CHD" --- p.7 / Chapter 1.2.3 --- High-density lipoprotein (HDL) cholesterol and CHD --- p.8 / Chapter 1.2.4 --- Triglyceride and CHD --- p.9 / Chapter 1.3 --- Cholesterol homeostasis --- p.10 / Chapter 1.3.1 --- Roles of HMG-CoA reductase in cholesterol biosynthesis --- p.13 / Chapter 1.3.2 --- Roles of cholesterol 7α-hydroxylase (CYP7A) in cholesterol catabolism…… --- p.15 / Chapter 1.3.3 --- Effects of Short-Chain Fatty Acid (SCFA) --- p.17 / Chapter 1.3.4 --- Related hormone --- p.18 / Chapter 1.4 --- Possible mechanisms of hypolipidemic agents --- p.19 / Chapter 1.4.1 --- Hypolipidemic functional foods --- p.20 / Chapter 1.4.2 --- Pharmacological drugs --- p.26 / Chapter 1.5 --- Edible and medicinal mushrooms --- p.28 / Chapter 1.5.1 --- General introduction --- p.28 / Chapter 1.5.2 --- Hypolipidemic agents from Fungi --- p.31 / Chapter 1.6 --- Animal model --- p.35 / Chapter 1.7 --- Objectives --- p.36 / Chapter CHAPTER TWO: --- MATERIALS AND METHODS --- p.37 / Chapter 2.1 --- Materials --- p.37 / Chapter 2.1.1 --- Mushroom samples and control --- p.37 / Chapter 2.1.1.1 --- Sample introduction --- p.37 / Chapter 2.1.1.2 --- Sample collection --- p.40 / Chapter 2.1.1.3 --- Sample preparation --- p.41 / Chapter 2.1.1.4 --- Moisture content --- p.45 / Chapter 2.1.2 --- Animal diets for different experiments --- p.45 / Chapter 2.1.2.1 --- Basal diet --- p.45 / Chapter 2.1.2.2 --- Diet for preliminary screening --- p.46 / Chapter 2.1.2.3 --- Diet for dosage experiment --- p.46 / Chapter 2.1.2.4 --- Diet for active ingredient experiments --- p.47 / Chapter 2.1.2.5 --- Diet for long-term feeding experiment --- p.47 / Chapter 2.1.3 --- Animal model --- p.49 / Chapter 2.2 --- Methods --- p.49 / Chapter 2.2.1 --- Nutritional components of mushroom samples --- p.49 / Chapter 2.2.1.1 --- Crude protein content (Kjeldahl method) --- p.49 / Chapter 2.2.1.2 --- Total dietary fiber content --- p.50 / Chapter 2.2.1.3 --- Crude lipid content --- p.52 / Chapter 2.2.1.4 --- Ash content --- p.53 / Chapter 2.2.1.5 --- Moisture content --- p.53 / Chapter 2.2.2 --- Animal handling experiments --- p.54 / Chapter 2.2.2.1 --- Feeding experiment standards --- p.54 / Chapter 2.2.2.1.1 --- Feeding experiments of preliminary screening test --- p.54 / Chapter 2.2.2.1.2 --- Feeding experiments of dosage test --- p.55 / Chapter 2.2.2.1.3 --- Feeding experiments of solvent extracts from Agrocybe aegerita (Brig) Sing (AA) --- p.56 / Chapter 2.2.2.1.3.1 --- Fractionation of ethanol & water soluble components of AA --- p.56 / Chapter 2.2.2.1.3.2 --- Feeding experiments of ethanol & water soluble components of AA --- p.57 / Chapter 2.2.2.1.4 --- Feeding experiment of long-term test --- p.58 / Chapter 2.2.2.2 --- Blood sample collection --- p.58 / Chapter 2.2.2.3 --- Serum preparation --- p.58 / Chapter 2.2.2.4 --- Liver sample preparation --- p.58 / Chapter 2.2.2.5 --- Fecal sample preparation --- p.59 / Chapter 2.2.3 --- Determination of serum lipid profiles --- p.59 / Chapter 2.2.3.1 --- Serum total cholesterol (TC) assay --- p.59 / Chapter 2.2.3.2 --- Serum triglyceride (TG) assay --- p.60 / Chapter 2.2.3.3 --- Serum high-density lipoprotein (HDL) cholesterol assay --- p.61 / Chapter 2.2.3.3.1 --- Separation of HDL fraction --- p.61 / Chapter 2.2.3.3.2 --- HDL cholesterol (HDL-c) determination --- p.61 / Chapter 2.2.4 --- Determination of liver lipid profiles --- p.62 / Chapter 2.2.4.1 --- Liver total cholesterol (TC) level determination --- p.62 / Chapter 2.2.4.2 --- Determination of liver total lipid (TL) level --- p.64 / Chapter 2.2.5 --- Quantitative determination of fecal neutral & acidic sterols --- p.64 / Chapter 2.2.5.1 --- Separation of fecal neutral & acidic sterols --- p.64 / Chapter 2.2.5.2 --- Derivatisation of fecal neutral sterols --- p.65 / Chapter 2.2.5.3 --- Derivatisation of fecal acidic sterols --- p.65 / Chapter 2.2.5.4 --- Gas chromatographic analysis of fecal neutral & acidic sterols --- p.66 / Chapter 2.2.6 --- Assays of liver key enzymes in cholesterol metabolism --- p.67 / Chapter 2.2.6.1 --- Preparation of hepatic microsome --- p.67 / Chapter 2.2.6.2 --- Assay of HMG-CoA reductase activity --- p.68 / Chapter 2.2.6.3 --- Assay of CYP7A activity --- p.69 / Chapter 2.3 --- Data statistics --- p.71 / Chapter CHAPTER THREE: --- RESULTS AND DISCUSSION --- p.72 / Chapter 3.1 --- Preliminary screening of eleven mushrooms for their hypolipidemic effect in hyperlipidemic S.D. rats --- p.72 / Chapter 3.1.1 --- Body weight and food intake --- p.73 / Chapter 3.1.2 --- Effect of mushroom supplementation on serum lipid profiles --- p.75 / Chapter 3.1.2.1. --- Effect of mushroom supplementation on serum TC levels --- p.75 / Chapter 3.1.2.2. --- Effect of mushroom supplementation on serum TG levels --- p.77 / Chapter 3.1.2.3. --- Effect of mushroom supplementation on serum HDL levels --- p.79 / Chapter 3.1.2.4 --- Discussion of serum lipid profiles of S.D. rats fed M.S. diets in mushroom screening experiments --- p.83 / Chapter 3.1.3 --- Effect and discussion of mushroom supplementation on hepatic lipid profiles --- p.84 / Chapter 3.1.4 --- Effect and discussion of mushroom supplementation on fecal neutral sterol excretion --- p.87 / Chapter 3.1.5 --- Summary (mushroom screening experiments) --- p.90 / Chapter 3.2 --- Hypolipidemic effect of Agrocybe aegerita (Brig.) Sing (AA) in a dose response study in hyperlipidemic S.D. rats --- p.91 / Chapter 3.2.1 --- Nutritional composition of AA mushroom --- p.91 / Chapter 3.2.2 --- Body weight and food intake --- p.91 / Chapter 3.2.3 --- Effect of three different dosages of AA mushroom supplementation on blood lipid profiles of S.D. rats --- p.93 / Chapter 3.2.3.1 --- Effect of different dosages of AA mushroom supplementation diets on serum TC level --- p.93 / Chapter 3.2.3.2 --- Effect of different dosages of AA mushroom supplementation diets on serum TG level --- p.93 / Chapter 3.2.3.3 --- Effect of different dosages of AA mushroom supplementation diets on serum HDL level --- p.95 / Chapter 3.2.3.4 --- Discussion of different dosages of AA mushroom supplementation diets on serum lipid profiles --- p.97 / Chapter 3.2.4 --- Effect and discussion of three different dosages of AA mushroom supplementation on hepatic lipid profiles --- p.98 / Chapter 3.2.5 --- Effect and discussion of three different dosages of AA mushroom supplementation on fecal neutral & acidic sterol excretion --- p.101 / Chapter 3.2.6 --- Summary (dose response study) --- p.105 / Chapter 3.3 --- Hypolipidemic effect of ethanol extract (E.E.) & water extract (W.E.) from AA in hyperlipidemic S.D. rats --- p.106 / Chapter 3.3.1 --- Extraction yield --- p.106 / Chapter 3.3.2 --- Body weight & food intake --- p.106 / Chapter 3.3.3 --- Effect of AA extract supplementation on serum lipid profiles --- p.107 / Chapter 3.3.3.1 --- Effect of AA extract supplementation on serum TC level --- p.107 / Chapter 3.3.3.2 --- Effect of AA extract supplementation on serum TG level --- p.108 / Chapter 3.3.3.3 --- Effect of AA extract supplementation on serum HDL level --- p.109 / Chapter 3.3.4 --- Effect of AA extract supplementation on hepatic lipid profiles --- p.111 / Chapter 3.3.5 --- Effect of AA extract supplementation on fecal neutral & acidic sterols excretion --- p.111 / Chapter 3.3.6 --- Discussion (active fraction extract study) --- p.113 / Chapter 3.4 --- Long-term evaluation of the hypolipidemic effect of AA supplementation in normolipic S.D. rats --- p.116 / Chapter 3.4.1 --- Body weight & food intake --- p.116 / Chapter 3.4.2 --- Effect of long term AA supplementation on serum lipid profiles --- p.117 / Chapter 3.4.2.1 --- Effect of long term AA supplementation on serum TC level --- p.117 / Chapter 3.4.2.2 --- Effect of long term AA supplementation on serum TG level --- p.118 / Chapter 3.4.2.3 --- Effect of long term AA supplementation on serum HDL level --- p.119 / Chapter 3.4.3 --- Effect of long term AA supplementation on hepatic lipid profiles --- p.119 / Chapter 3.4.4 --- Effect of long term AA supplementation on fecal neutral & acidic sterols excretion --- p.121 / Chapter 3.4.5 --- Effect of long term AA supplementation on hepatic key enzymes of cholesterol metabolism ´ؤ HMG-CoA reductase and CYP7A --- p.123 / Chapter 3.4.5.1 --- Quantitation of hepatic microsomal protein --- p.123 / Chapter 3.4.5.2 --- Effect of long term AA supplementation on HMG-CoA reductase activity in S.D. rats --- p.124 / Chapter 3.4.5.3 --- Effect of long term AA supplementation on CYP7A activity in S.D. rats --- p.124 / Chapter 3.4.7 --- Discussion (long-term study) --- p.126 / Chapter CHAPTER FOUR: --- CONCLUSION AND FUTURE PERSPECTIVES --- p.130 / References --- p.136

Chan Yiu-Pong. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (leaves 98-112). / Abstracts in English and Chinese. / Abstract --- p.i / Acknowledgement --- p.v / Declaration --- p.vi / Table of content --- p.vii / List of Tables --- p.x / List of Figures --- p.xi / List of abbreviation --- p.xiv / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Introduction of Semen Oroxyli --- p.1 / Chapter 1.1.1 --- Chemical constituents of Oroxylum indicum seed --- p.3 / Chapter 1.1.2 --- Pharmacological studies --- p.3 / Chapter 1.2 --- Introduction to tracheal secretion --- p.6 / Chapter 1.2.1 --- Mucus composition --- p.6 / Chapter 1.2.2 --- Sputum formation --- p.6 / Chapter 1.2.3 --- Expectorant --- p.7 / Chapter 1.2.3.1 --- Secretolytic drugs --- p.7 / Chapter 1.2.3.2 --- Mucolytic drugs --- p.8 / Chapter 1.2.4 --- Assays of studying expectorant activity --- p.10 / Chapter 1.2.4.1 --- Tracheal phenol red secretion system --- p.10 / Chapter 1.3 --- Introduction to oxidant and antioxidant --- p.11 / Chapter 1.3.1 --- Oxidants/ reactive oxygen species --- p.11 / Chapter 1.3.1.1 --- Production of oxidants/ reactive oxygen species --- p.11 / Chapter 1.3.1.2 --- Reactive oxygen species reaction products --- p.12 / Chapter 1.3.1.2.1 --- DNA damage --- p.13 / Chapter 1.3.1.2.2 --- Protein damage --- p.13 / Chapter 1.3.1.2.3 --- Lipid damage --- p.14 / Chapter 1.3.2 --- Antioxidant --- p.14 / Chapter 1.3.2.1 --- Endogenous antioxidants --- p.15 / Chapter 1.3.2.1.1 --- Superoxide dismutase --- p.15 / Chapter 1.3.2.1.2 --- Catalase --- p.15 / Chapter 1.3.2.1.3 --- Glutathione and glutathione peroxidases --- p.15 / Chapter 1.3.3 --- Synthetic and natural antioxidants --- p.16 / Chapter 1.3.3.1 --- Vitamin C --- p.17 / Chapter 1.3.3.2 --- Tocopherols (Vitamin E) --- p.17 / Chapter 1.3.4 --- Assays for studying antioxidative activities --- p.19 / Chapter 1.3.4.1 --- DPPH radical scavenging system --- p.19 / Chapter 1.3.4.2 --- PMS-NADH system --- p.19 / Chapter 1.3.4.3 --- APPH-induced hemolysis system --- p.20 / Chapter 1.4 --- Objectives of the research --- p.22 / Chapter Chapter 2 --- Materials and Methods --- p.24 / Chapter 2.1 --- Materials --- p.24 / Chapter 2.1.1 --- Semen Oroxyli --- p.24 / Chapter 2.1.2 --- Animals --- p.24 / Chapter 2.1.3 --- Chemicals --- p.25 / Chapter 2.2 --- Methods --- p.28 / Chapter 2.2.1 --- Assay for studying expectorant activity --- p.28 / Chapter 2.2.1.1 --- Phenol red standard curve --- p.28 / Chapter 2.2.1.2 --- Tracheal phenol red secretion system --- p.28 / Chapter 2.2.2 --- Assays for studying antioxidative activity --- p.30 / Chapter 2.2.2.1 --- DPPH radicals scavenging system --- p.30 / Chapter 2.2.2.2 --- PMS-NADH system --- p.31 / Chapter 2.2.2.3 --- AAPH-induced red blood cell hemolysis system --- p.32 / Chapter 2.2.3 --- "Extraction, fractionation and purification of Semen Oroxyli" --- p.33 / Chapter 2.2.3.1 --- 70% ethanol extraction of Semen Oroxyli --- p.33 / Chapter 2.2.3.2 --- Fractionation in polyamide column --- p.33 / Chapter 2.2.3.3 --- Fractionation in resin column --- p.34 / Chapter 2.2.3.4 --- Sub-fractions separation from 95% ethanol soluble fraction --- p.34 / Chapter 2.2.3.5 --- Pure compounds obtained from sub-fractions --- p.34 / Chapter 2.2.4 --- Nulcear magnetic resonance (NMR) for identification --- p.38 / Chapter Chapter 3 --- Results of Expectorant Activity --- p.39 / Chapter 3.1 --- Expectorant Activity --- p.39 / Chapter 3.1.1 --- Expectorant Activity on Semen Oroxyli ethanol extract --- p.39 / Chapter 3.1.2 --- Expectorant activities of fractionations of Semen Oroxyli ethanol extract --- p.39 / Chapter Chapter 4 --- Results of Antioxidative Activity --- p.44 / Chapter 4.1 --- Antioxidative activity --- p.44 / Chapter 4.1.1 --- Antioxidative activity of 70% ethanol extract --- p.44 / Chapter 4.1.2 --- Antioxidative activity of fractions of 70% ethanol extract --- p.49 / Chapter 4.1.3 --- Antioxidative activity on sub-fractions fractionated from 95% ethanol-soluble fraction --- p.50 / Chapter 4.1.4 --- Antioxidative activity on pure compounds isolated from sub-fractions --- p.59 / Chapter Chapter 5 --- Results of Identification of Pure compounds --- p.68 / Chapter 5.1 --- Identification of compounds --- p.68 / Chapter 5.1.1 --- Compound A --- p.68 / Chapter 5.1.2 --- Compound B --- p.69 / Chapter 5.1.3 --- Compound C --- p.69 / Chapter 5.1.4 --- Compound D --- p.70 / Chapter 5.1.5 --- Compound E --- p.71 / Chapter Chapter 6 --- Discussion --- p.73 / Chapter 6.1 --- Discussion of expectorant activity of Semen Oroxyli --- p.73 / Chapter 6.2 --- Discussion of antioxidative activity of Semen Oroxyli --- p.75 / Chapter 6.3 --- General Discussion --- p.77 / Chapter Chapter 7 --- Conclusions --- p.82 / Appendix A Procedures for preparing the phenol red standard curve for tracheal phenol red secretion system. --- p.85 / Appedix B 1H NMR and 13C NMR spectra --- p.87 / References --- p.98

Zhang Li. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2003. / Includes bibliographical references (leaves 148-159). / Abstracts in English and Chinese. / Acknowledgements --- p.I / Abstract --- p.II / Abstract (in Chinese) --- p.IV / Publications --- p.V / List of Abbreviations --- p.VI / List of Tables --- p.VII / List of Figures --- p.VIII / Table of Contents --- p.XIII / Chapter Chapter One. --- Introduction --- p.1 / Chapter 1.1 --- Flavonoids --- p.1 / Chapter 1.2 --- Tea --- p.4 / Chapter 1.2.1 --- Composition of green tea catechins (GTC) --- p.4 / Chapter 1.2.2 --- Pharmacological activity --- p.6 / Chapter 1.2.2.1 --- Anticarcinogenic activity --- p.6 / Chapter 1.2.2.2 --- Antioxidative activity --- p.7 / Chapter 1.2.2.3 --- Radical scavenge --- p.7 / Chapter 1.2.2.4 --- Cardiovascular activity --- p.8 / Chapter 1.2.3 --- Pharmacokinetics of GTC --- p.8 / Chapter 1.2.3.1 --- Absorption --- p.10 / Chapter 1.2.3.2 --- Distribution --- p.11 / Chapter 1.2.3.3 --- Elimination --- p.11 / Chapter 1.2.3.4 --- Metabolism --- p.12 / Chapter 1.2.3.4.1 --- Metabolism in the small intestine --- p.12 / Chapter 1.2.3.4.2 --- Metabolism in the liver --- p.13 / Chapter 1.2.3.5 --- Summary of the pharmacokinetics of GTC --- p.13 / Chapter 1.3 --- Hawthorn --- p.14 / Chapter 1.3.1 --- Composition of hawthorn --- p.14 / Chapter 1.3.2 --- Pharmacological activity --- p.16 / Chapter 1.3.2.1 --- Inotonic activity --- p.16 / Chapter 1.3.2.2 --- Antiarrhythmic activity --- p.17 / Chapter 1.3.2.3 --- Hypolipidemic activity --- p.17 / Chapter 1.3.2.4 --- Antihypertensive activity --- p.18 / Chapter 1.3.2.5 --- Antioxidative activity --- p.18 / Chapter 1.3.3 --- Pharmacokinetics of HF --- p.18 / Chapter 1.3.3.1 --- Absorption --- p.19 / Chapter 1.3.3.2 --- Distribution and elimination --- p.21 / Chapter 1.3.3.3 --- Summary of pharmacokinetic of HF --- p.22 / Chapter 1.4 --- Mechanisms of intestinal absorption --- p.22 / Chapter 1.4.1 --- Passive transcellular transport --- p.23 / Chapter 1.4.2 --- Paracellular transport --- p.23 / Chapter 1.4.3 --- Carrier-mediated transport --- p.23 / Chapter 1.5 --- ABC transporters --- p.24 / Chapter 1.5.1 --- Cellular location and tissue distribution --- p.25 / Chapter 1.5.2 --- Substrates and inhibitors of ABC transporters --- p.26 / Chapter 1.6 --- Oral absorption models --- p.31 / Chapter 1.6.1 --- Ussing chamber --- p.31 / Chapter 1.6.2 --- In situ intestinal perfusion model --- p.33 / Chapter 1.6.3 --- Cell culture model --- p.34 / Chapter 1.7 --- Aims of the study --- p.36 / Chapter Chapter Two. --- Transport mechanism of green tea catechins --- p.37 / Chapter 2.1 --- Introduction --- p.37 / Chapter 2.2 --- Materials --- p.38 / Chapter 2.2.1 --- Chemicals --- p.38 / Chapter 2.2.2 --- Materials for cell culture --- p.38 / Chapter 2.2.3 --- Instruments --- p.39 / Chapter 2.3 --- Methods --- p.39 / Chapter 2.3.1 --- Analytical methods --- p.39 / Chapter 2.3.1.1 --- Analytical methods for validation of Caco-2 model --- p.39 / Chapter 2.3.1.1.1 --- Fluorescence analysis of lucifer yellow --- p.39 / Chapter 2.3.1.1.2 --- HPLC analysis of propranolol --- p.39 / Chapter 2.3.1.1.3 --- HPLC analysis of verapamil --- p.40 / Chapter 2.3.1.1.4 --- HPLC analysis of quinidine --- p.40 / Chapter 2.3.1.2 --- Analytical methods for samples contained GTC --- p.41 / Chapter 2.3.1.2.1 --- HPLC analysis for each GTC --- p.41 / Chapter 2.3.1.2.2 --- Preparation of calibration curves for each GTC --- p.42 / Chapter 2.3.1.2.3 --- HPLC/MS analysis of samples containing mixtures of four GTC --- p.42 / Chapter 2.3.1.2.4 --- Preparation of calibration curves for samples containing GTC mixture --- p.43 / Chapter 2.3.1.2.5 --- Validation of the HPLC methods --- p.43 / Chapter 2.3.1.3 --- Identification of metabolites with HPLC/MS --- p.44 / Chapter 2.3.2 --- Determination of stability profile of GTC in phosphate buffer --- p.44 / Chapter 2.3.3 --- Cell culture --- p.45 / Chapter 2.3.4 --- Validation of Caco-2 cell monolayer model --- p.46 / Chapter 2.3.4.1 --- Integrity of Caco-2 cell monolayer at pH 6.0 --- p.46 / Chapter 2.3.4.2 --- Permeability of paracellular and transcellular markers at pH 6.0 --- p.46 / Chapter 2.3.4.3 --- Validation of the existence of P-glycoprotein (P-gp) transporterin Caco-2 monolayer model --- p.46 / Chapter 2.3.4.4 --- Cytotoxicity test --- p.47 / Chapter 2.3.5 --- Transport study of GTC using Caco-2 cell monolayer model --- p.48 / Chapter 2.3.5.1 --- Bi-directional transport experiment --- p.48 / Chapter 2.3.5.2 --- Preparation of different dosing formulations of GTC --- p.48 / Chapter 2.3.5.2.1 --- Preparation of individual pure GTC solutions --- p.48 / Chapter 2.3.5.2.2 --- Preparation of cocktail 1 solution --- p.49 / Chapter 2.3.5.2.3 --- Preparation of green tea extract solution --- p.49 / Chapter 2.3.5.2.4 --- Preparation of cocktail 2 solution --- p.50 / Chapter 2.3.5.3 --- Sample treatment --- p.50 / Chapter 2.3.5.3.1 --- Samples for direct analysis --- p.50 / Chapter 2.3.5.3.2 --- Samples for enzymatic hydrolysis treatment --- p.51 / Chapter 2.3.5.4 --- Further investigation of the transport mechanism of GTC --- p.51 / Chapter 2.3.5.4.1 --- Inhibition transport of EC and EGC --- p.51 / Chapter 2.3.5.4.2 --- Transport mechanism of metabolites of EC and EGC --- p.52 / Chapter 2.3.5.4.3 --- Metabolic competition between EGC and the other GTC --- p.52 / Chapter 2.3.6 --- Calculation --- p.53 / Chapter 2.3.7 --- Data analysis --- p.54 / Chapter 2.4 --- Results --- p.55 / Chapter 2.4.1 --- Validation of the HPLC methods --- p.55 / Chapter 2.4.2 --- Stability of the GTC --- p.55 / Chapter 2.4.3 --- Extract of green tea leaves --- p.55 / Chapter 2.4.4 --- Validation of Caco-2 model --- p.59 / Chapter 2.4.4.1 --- Integrity of Caco-2 cell monolayer --- p.59 / Chapter 2.4.4.2 --- Permeability of paracellular and transcellular markers at pH 6.0 --- p.59 / Chapter 2.4.4.3 --- Validation of P-glycoprotein --- p.60 / Chapter 2.4.4.4 --- Cytotoxicity test --- p.61 / Chapter 2.4.5 --- Transport study of GTC --- p.63 / Chapter 2.4.5.1 --- Bi-directional transport of individual pure GTC --- p.63 / Chapter 2.4.5.2 --- Bi-directional transport of GTC in different dosing formulations --- p.66 / Chapter 2.4.5.2.1 --- Absorption transport profile of GTC in different dosing formulations --- p.66 / Chapter 2.4.5.2.2 --- Secretion transport profile of GTC in different dosing formulations --- p.66 / Chapter 2.4.5.3 --- Identification of metabolites of each GTC formed during the transport in Caco-2 cell model --- p.71 / Chapter 2.4.6 --- Further investigation of the transport mechanism of GTC --- p.82 / Chapter 2.4.6.1 --- Inhibition transport of EC and EGC --- p.82 / Chapter 2.4.6.2 --- Transport mechanism of metabolites of EC and EGC --- p.82 / Chapter 2.4.6.3 --- Metabolic competition between EGC and the other GTC --- p.85 / Chapter 2.4.6.4 --- Contribution of GTC on the metabolism of EGC --- p.89 / Chapter 2.5 --- Discussion --- p.92 / Chapter 2.5.1 --- Stability of the four GTC --- p.92 / Chapter 2.5.2 --- Validation of Caco-2 cell model --- p.92 / Chapter 2.5.3 --- Bi-directional transport of GTC --- p.93 / Chapter 2.5.4 --- Structure related efflux --- p.97 / Chapter 2.5.5 --- Metabolism of GTC --- p.98 / Chapter 2.5.6 --- Relationship between metabolism and efflux transport of GTC --- p.99 / Chapter 2.5.7 --- Bi-directional transport of GTC in different dosing formulations …… --- p.100 / Chapter 2.5.7.1 --- Absorption transport profile of different dosing formulations --- p.100 / Chapter 2.5.7.2 --- Secretion transport profile of different dosing formulations --- p.101 / Chapter 2.6 --- Conclusion --- p.105 / Chapter Chapter Three. --- Transport mechanism of hawthorn flavonoids --- p.106 / Chapter 3.1 --- Introduction --- p.106 / Chapter 3.2 --- Materials --- p.107 / Chapter 3.2.1 --- Chemicals --- p.107 / Chapter 3.2.2 --- Materials for cell culture --- p.108 / Chapter 3.2.3 --- Instruments --- p.108 / Chapter 3.3 --- Methods --- p.109 / Chapter 3.3.1 --- Analytical methods for HF --- p.109 / Chapter 3.3.1.1 --- Analytical methods of individual pure compound of HF --- p.109 / Chapter 3.3.1.1.1 --- HPLC analysis of HP and IQ --- p.109 / Chapter 3.3.1.1.2 --- HPLC analysis of EC --- p.109 / Chapter 3.3.1.2 --- Preparation of calibration curves for individual pure HF --- p.109 / Chapter 3.3.1.3 --- HPLC/MS analysis of three HF in mixture --- p.110 / Chapter 3.3.1.4 --- Preparation of the calibration curves of three HF in mixture --- p.111 / Chapter 3.3.1.5 --- Validation of HPLC methods --- p.111 / Chapter 3.3.2 --- Analytical methods for identification of metabolites with HPLC/MS --- p.111 / Chapter 3.3.3 --- Cell culture --- p.112 / Chapter 3.3.4 --- Cytotoxicity test --- p.113 / Chapter 3.3.5 --- Transport studies of HF using Caco-2 monolayer model --- p.113 / Chapter 3.3.5.1 --- Bi-directional transport experiment --- p.113 / Chapter 3.3.5.2 --- Preparation of loading solutions in different dosing formulations of HF for Caco-2 cell model --- p.114 / Chapter 3.3.5.2.1 --- Preparation of individual pure HF solutions --- p.114 / Chapter 3.3.5.2.2 --- Preparation of cocktail 1 solution --- p.114 / Chapter 3.3.5.2.3 --- Preparation of hawthorn extract solution --- p.114 / Chapter 3.3.5.2.4 --- Preparation of cocktail 2 solution --- p.114 / Chapter 3.3.5.3 --- Sample treatment --- p.115 / Chapter 3.3.5.4 --- Further study of the transport mechanism of HF --- p.115 / Chapter 3.3.5.4.1 --- "Inhibition transport of EC, IQ, and HP" --- p.115 / Chapter 3.3.5.4.2 --- "Transport mechanisms of the metabolites of EC, HP, IQ" --- p.116 / Chapter 3.3.6 --- Calculation --- p.116 / Chapter 3.3.7 --- Data analysis --- p.117 / Chapter 3.4 --- Results --- p.118 / Chapter 3.4.1 --- Validation of the HPLC methods --- p.118 / Chapter 3.4.2 --- Cytotoxicity test --- p.118 / Chapter 3.4.3 --- Transport study of HF --- p.122 / Chapter 3.4.3.1 --- Bi-directional transport of individual pure HF --- p.122 / Chapter 3.4.3.2 --- Bi-directional transport of the HF in different formulations --- p.123 / Chapter 3.4.3.2.1 --- Absorption transport of different formulations of HF --- p.123 / Chapter 3.4.3.2.2 --- Secretion transport of different dosing forms --- p.123 / Chapter 3.4.3.3 --- Identification of metabolites of each HF formed during their transport in Caco-2 model --- p.126 / Chapter 3.4.4 --- Further study on the transport mechanism --- p.136 / Chapter 3.4.4.1 --- "Inhibition transport of EC, HP, IQ" --- p.136 / Chapter 3.4.4.2 --- Transport mechanism of metabolites of HF --- p.136 / Chapter 3.4.4.3 --- Transport profiles of HF metabolites upon the loading of different dosing formulations of HF --- p.138 / Chapter 3.5 --- Discussion --- p.140 / Chapter 3.5.1 --- Bi-directional transport of each HF --- p.140 / Chapter 3.5.2 --- Bi-directional transport of HF in different formulations --- p.141 / Chapter 3.6 --- Conclusion --- p.142 / Chapter Chapter Four. --- Limitations of the current study --- p.143 / Chapter Chapter Five. --- Overall conclusions --- p.146 / References --- p.148 / Appendices --- p.160

Chen Qian. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (leaves 141-156). / Abstract and questionnaires in English and Chinese. / ABSTRACT --- p.I / 中文摘要 --- p.III / ACKNOWLEDGEMENTS --- p.IV / ABBREVIATIONS --- p.V / LIST OF TABLES --- p.VII / TABLE OF CONTENTS --- p.IX / Chapter CHAPTER 1: --- INTRODUCTION --- p.1 / Chapter 1.1 --- "General principles of diagnosis, treatment and efficacy evaluation in TCM" --- p.3 / Chapter 1.1.1 --- Basic principle of TCM in diagnosis and treatment --- p.3 / Chapter 1.1.2 --- Principles of combination use of TCM --- p.3 / Chapter 1.1.3 --- Principles of TCM prescription --- p.5 / Chapter 1.2 --- TCM is beneficial to human health --- p.6 / Chapter 1.2.1 --- "TCM is beneficial, but needs further modernized confirmation" --- p.6 / Chapter 1.2.2 --- TCM is effective when used following the principles of TCM --- p.21 / Chapter 1.2.3 --- The proper use and efficacy of TCM need further investigations --- p.21 / Chapter 1.3 --- Unwanted effects of TCM --- p.24 / Chapter 1.3.1 --- Unwanted effects of TCM are commonly seen --- p.24 / Chapter 1.3.2 --- Adverse effects of TCM classified based on medical systems --- p.25 / Chapter 1.3.3 --- Reasons related to adverse effects of TCM --- p.30 / Chapter 1.4 --- Studies on the use of TCM in Hong Kong --- p.31 / Chapter 1.5 --- Hypothesis and purpose of this study --- p.33 / Chapter CHAPTER 2: --- METHODOLOGY --- p.34 / Chapter 2.1 --- Rationale of questionnaire survey --- p.34 / Chapter 2.1.1 --- Choice of study method --- p.34 / Chapter 2.1.2 --- Types of diseases in the survey --- p.39 / Chapter 2.2 --- Issues related to implementation of questionnaire survey --- p.39 / Chapter 2.2.2 --- Interviewers and respondents --- p.40 / Chapter 2.2.3 --- Materials of the survey --- p.41 / Chapter 2.2.4 --- Collection period of questionnaire form --- p.42 / Chapter 2.2.5 --- Procedure of the questionnaire survey --- p.42 / Chapter 2.3 --- Questionnaire format and the content --- p.44 / Chapter 2.4 --- Statistics methods --- p.46 / Chapter 2.5 --- Pilot study for validation of the survey --- p.46 / Chapter CHAPTER 3: --- RESULTS --- p.48 / Chapter 3.1 --- Results from the main patient survey --- p.48 / Chapter 3.1.1 --- General characteristics of main patient group…… --- p.48 / Chapter 3.1.2 --- The attitude of the main patient group towards TCM --- p.48 / Chapter 3.1.3 --- Use of herbal medicines in the main patient group --- p.49 / Chapter 3.1.3.1 --- Chinese herbal medicines used for tonics or food supplements --- p.51 / Chapter 3.1.3.2 --- Chinese herbal medicines used for treating illnesses --- p.52 / Chapter 3.2 --- Results from medical patients --- p.55 / Chapter 3.2.1 --- General characteristics of medical patients in the survey --- p.55 / Chapter 3.2.2 --- The attitude of medical patients towards TCM --- p.56 / Chapter 3.2.3 --- Use of herbal medicines in medical patients --- p.57 / Chapter 3.2.3.1 --- Chinese herbal medicines used for tonics or food supplements --- p.57 / Chapter 3.2.3.2 --- Chinese herbal medicines used for treating illnesses --- p.58 / Chapter 3.2.4 --- Use of herbal medicine in the patients with the metabolic syndrome --- p.61 / Chapter 3.2.4.1 --- About the patients with hypertension and/or dyslipidaemia --- p.62 / Chapter 3.2.4.2 --- About the patients with diabetes mellitus --- p.63 / Chapter 3.3 --- Results from surgical patients --- p.64 / Chapter 3.3.1 --- General characteristics of surgical patients --- p.64 / Chapter 3.3.2 --- The attitude of surgical patients towards TCM --- p.65 / Chapter 3.3.3 --- Use of herbal medicines in surgical patients --- p.66 / Chapter 3.3.3.1 --- Chinese herbal medicines used for tonics or food supplements --- p.66 / Chapter 3.3.3.2 --- Chinese herbal medicines used for treating illnesses --- p.67 / Chapter 3.3.3.3 --- TCM used in gynaecological and surgical patients --- p.70 / Chapter CHAPTER 4: --- DISCUSSION --- p.73 / Chapter 4.1 --- The use of TCM in Hong Kong patients --- p.73 / Chapter 4.2 --- The attitude of patients towards TCM --- p.82 / Chapter 4.3 --- Limitations in the survey --- p.83 / Chapter 4.4 --- Further investigations --- p.89 / Chapter CHAPTER 5: --- CONCLUSIONS --- p.90 / Chapter 5.1 --- TCM is commonly used in Hong Kong patients for either health promotion or illnesses prevention and treatment --- p.90 / Chapter 5 2 --- The use of TCM in Hong Kong patients lacks formal regulation and management --- p.90 / TABLES --- p.91 / APPENDIX --- p.133 / Chapter 1. --- Informed consent form --- p.133 / Chapter 2. --- Questionnaire form (English version) --- p.136 / Chapter 3. --- Questionnaire form (Chinese version) --- p.138 / BIBLIOGRAPHY --- p.141 / Chapter 1. --- Full Publications --- p.141 / Chapter 2. --- Conference abstracts --- p.141 / REFERENCES --- p.144

Lam Kit. / Thesis submitted in: July 2002. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (leaves 141-153). / Abstracts in English and Chinese. / Acknowledgment --- p.I / Table of Content --- p.II / List of Tables --- p.VII / List of Figures --- p.IX / Abbreviations --- p.XIV / Abstract --- p.XVI / 論文摘要 --- p.XIX / Chapter CHAPTER 1 --- INTRODUCTION --- p.1 / Chapter 1.1 --- Hepatitis B --- p.1 / Chapter 1.1.1 --- Brief Introduction of HBV --- p.1 / Chapter 1.1.2 --- History of Hepatitis B Virus --- p.2 / Chapter 1.1.3 --- Hepatitis B Virus Infection around the World --- p.4 / Chapter 1.1.4 --- Hepatitis B Virus Infection in Hong Kong --- p.5 / Chapter 1.1.5 --- Hepatitis B Virus Infection in China --- p.7 / Chapter 1.1.5.1 --- Update of HBV Infection in China --- p.7 / Chapter 1.1.5.2 --- Problems in China --- p.7 / Chapter 1.2 --- Hepatitis B Virology --- p.8 / Chapter 1.2.1 --- Hepadnaviridae Family --- p.8 / Chapter 1.2.2 --- HBV Particles Types --- p.9 / Chapter 1.2.3 --- The HBV Genome --- p.10 / Chapter 1.2.4 --- The Life Cycle of HBV --- p.12 / Chapter 1.2.5 --- Hepatitis B Surface Antigen (HBsAg) --- p.17 / Chapter 1.3 --- HBV Transmission --- p.19 / Chapter 1.4 --- HBV Therapy --- p.19 / Chapter 1.5 --- Phyllanthus Species --- p.22 / Chapter 1.6 --- Alexander Cells --- p.26 / Chapter 1.7 --- Objectives --- p.29 / Chapter CHAPTER 2 --- COMPARISONS OF AQUEOUS AND ORGANIC EXTRACTS OF THREE PHYLLANTHUS SPECIES OF THEIR IN VITRO ANTI-HBV EFFECTS --- p.30 / Chapter 2.1 --- Introduction --- p.30 / Chapter 2.2 --- Materials and Methods --- p.30 / Chapter 2.2.1 --- Materials --- p.30 / Chapter 2.2.1.1 --- Phyllanthus species --- p.30 / Chapter 2.2.1.2 --- "Chemicals, Antibodies and Instrument" --- p.31 / Chapter 2.2.2 --- Extraction Methods --- p.32 / Chapter 2.2.2.1 --- Aqueous Extraction --- p.33 / Chapter 2.2.2.2 --- Organic Extraction --- p.33 / Chapter 2.2.3 --- Cell line --- p.33 / Chapter 2.2.4 --- Toxicity of Extracts --- p.34 / Chapter 2.2.5 --- IMx Assay --- p.34 / Chapter 2.2.6 --- Semi-quantitative RT-PCR --- p.35 / Chapter 2.2.6.1 --- RNA Extraction --- p.35 / Chapter 2.2.6.2 --- RT-PCR --- p.36 / Chapter 2.2.7 --- Western Blotting --- p.37 / Chapter 2.2.7.1 --- Preparation of Protein Samples --- p.37 / Chapter 2.2.7.2 --- Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) --- p.37 / Chapter 2.2.7.3 --- Protein Transfer --- p.38 / Chapter 2.2.7.4 --- Immumnoblotting --- p.39 / Chapter 2.2.7.5 --- Protein Assay --- p.39 / Chapter 2.3 --- Results --- p.40 / Chapter 2.3.1 --- Toxicity of the Extracts --- p.40 / Chapter 2.3.2 --- Effects on HBsAg Secretion and Viral Gene Expression --- p.45 / Chapter 2.3.2 --- Analysis of Intracellular Viral Proteins --- p.58 / Chapter 2.4 --- Discussion --- p.63 / Chapter CHAPTER 3 --- ISOLATION AND CHARACTERIZATION OF ACTIVE COMPONIENT FROM AN ORGANIC EXTRACT OF PHYLLANTHUS URINARIA (GUANGDONG) --- p.68 / Chapter 3.1 --- Introduction --- p.68 / Chapter 3.2 --- Materials and Methods --- p.69 / Chapter 3.2.1 --- Materials --- p.69 / Chapter 3.2.2 --- Methods --- p.70 / Chapter 3.2.2.1 --- Ethanol Extraction --- p.70 / Chapter 3.2.2.2 --- Partitions --- p.70 / Chapter 3.2.2.3 --- Column Purification --- p.71 / Chapter 3.2.2.4 --- Analytical Thin Layer Chromatographic (TLC) --- p.71 / Chapter 3.2.2.5 --- Crystallization --- p.71 / Chapter 3.3 --- Results --- p.72 / Chapter 3.3.1 --- Analysis of Four Fractions after Partitions --- p.72 / Chapter 3.3.2 --- Screening of the Active Fraction after Column Chromatography of Fraction B --- p.76 / Chapter 3.3.3 --- Screening of the Active Fraction after Column Chromatography of Fraction6 --- p.79 / Chapter 3.3.4 --- Crystallization and Identification of the Isolated component --- p.82 / Chapter 3.3.5 --- Study Anti-HBV effects of pheophorbide a --- p.91 / Chapter 3.4 --- Discussion --- p.97 / Chapter CHAPTER 4 --- STUDY OF PRE S I PROMOTER ACTIVITY OF HBV --- p.103 / Chapter 4.1 --- Introduction --- p.103 / Chapter 4.2 --- Materials and Methods --- p.108 / Chapter 4.2.1 --- Materials --- p.108 / Chapter 4.2.2 --- Methods --- p.109 / Chapter 4.2.2.1 --- Cell line --- p.109 / Chapter 4.2.2.2 --- Clonning of Pre SI Promoter from HBV Genome --- p.109 / Chapter 4.2.2.3 --- Gene Clean --- p.110 / Chapter 4.2.2.4 --- Restriction Enzyme Digestion --- p.111 / Chapter 4.2.2.5 --- Synthesis of T-Overhang EcoR V Cut pBluescript® II KS (-) --- p.111 / Chapter 4.2.2.6 --- Ligation --- p.112 / Chapter 4.2.2.7 --- DH5α Competent Cells Preparation --- p.112 / Chapter 4.2.2.8 --- Transformation --- p.113 / Chapter 4.2.2.9 --- Plasmid Purification --- p.113 / Chapter 4.2.2.10 --- Transfection --- p.114 / Chapter 4.2.2.11 --- Luciferase Assay --- p.115 / Chapter 4.3 --- Results --- p.116 / Chapter 4.3.1 --- Cloning of the Pre S I Promoter --- p.116 / Chapter 4.3.2 --- Sequences of the Pre S I Promoter --- p.121 / Chapter 4.3.3 --- Pre S I Promoter Activities in Hep 3B Cell Line --- p.123 / Chapter 4.3.4 --- Effects of Herbal Extracts on Pre S I Promoter --- p.126 / Chapter 4.4 --- Discussion --- p.130 / Chapter CHAPTER 5 --- GENERAL DISCUSSION --- p.134 / REFERENCES --- p.141

Yim Wan Sze. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2004. / Includes bibliographical references (leaves 95-109). / Abstracts in English and Chinese. / Acknowledgements --- p.i / Abstract --- p.ii / 槪論 --- p.iv / Table of contents --- p.v / List of abbreviations --- p.xii / List of Figures --- p.xv / List of Tables --- p.xviii / Chapter Chapter 1 --- Introduction --- p.1 / Chapter 1.1 --- Oxidation stress --- p.1 / Chapter 1.1.1 --- Free radicals --- p.2 / Chapter 1.1.1.1 --- Hydrogen peroxide --- p.3 / Chapter 1.1.1.2 --- Menadione --- p.4 / Chapter 1.1.2 --- Diseases related to oxidative stress --- p.5 / Chapter 1.1.3 --- Liver Injury --- p.5 / Chapter 1.1.4 --- Antioxidants --- p.7 / Chapter 1.1.4.1 --- Importance of antioxidant --- p.7 / Chapter 1.1.4.2 --- Examples of antioxidant --- p.7 / Chapter 1.2 --- Traditional Chinese Medicinal (TCM) formula Wu-zi-yan-zong-wan (WZ) --- p.8 / Chapter 1.2.1 --- The WZ medicinal formula --- p.8 / Chapter 1.2.2 --- Pharmacological actions of WZ --- p.9 / Chapter 1.2.3 --- Pharmacological actions of individual herbs --- p.10 / Chapter 1.2.3.1 --- Fructus Lycii --- p.10 / Chapter 1.2.3.2 --- Semen Cuscuta --- p.11 / Chapter 1.2.3.3 --- Fructus Rubi --- p.12 / Chapter 1.2.3.4 --- Semen Plantaginis --- p.12 / Chapter 1.2.3.5 --- Fructus Schisandrae --- p.13 / Chapter 1.3 --- The relationship between the liver and kidney --- p.14 / Chapter 1.4 --- Objectives of study --- p.15 / Chapter Chapter 2 --- Preparation of Aqueous Extraction of Wu-zi-yan-zong-wan --- p.17 / Chapter 2.1 --- Introduction --- p.17 / Chapter 2.2 --- Materials and Methods --- p.18 / Chapter 2.2.1 --- Preparation of Wu-zi-yan-zong-wan (WZ) --- p.18 / Chapter 2.2.1.1 --- WZ extracts from raw materials (WZ-e) --- p.18 / Chapter 2.2.1.2 --- WZ extracts from commercial available ready-to-use powders (WZ-p) --- p.20 / Chapter 2.3 --- Results --- p.22 / Chapter 2.3.1 --- Extraction Yield for WZ-e --- p.22 / Chapter Chapter 3 --- In vitro Total Antioxidant Capacity of Aqueous Extracts of Wu-zi-yan-zong-wan and its Components --- p.24 / Chapter 3.1 --- Introduction --- p.24 / Chapter 3.1.1 --- Total Antioxidants: Trolox Equavalent Antioxidant Capacity (TEAC) --- p.24 / Chapter 3.1.2 --- Objectives --- p.25 / Chapter 3.2 --- Materials and methods --- p.26 / Chapter 3.2.1 --- Materials --- p.26 / Chapter 3.2.1.1 --- Reagents --- p.26 / Chapter 3.2.1.2 --- Instruments --- p.26 / Chapter 3.2.2 --- Methods --- p.26 / Chapter 3.2.2.1 --- Total Antioxidnats: Trolox Equavalent Antioxidnat Capacity (TEAC) --- p.26 / Chapter 3.2.3 --- Statistical analysis --- p.27 / Chapter 3.3 --- Results --- p.28 / Chapter 3.3.1 --- Antioxidnat Capacity of Trolox --- p.28 / Chapter 3.3.2 --- Antioxidant capacity of WZ-e formula --- p.28 / Chapter 3.3.3 --- Antioxidant capacity of WZ-p formula --- p.28 / Chapter 3.3.4 --- The total antioxidant capacity of WZ-e and its simplified formulae --- p.32 / Chapter 3.3.5 --- The total antioxidant capacity of WZ-p and its simplified formulae --- p.32 / Chapter 3.3.6 --- Synergetic effect of WZ-e and its simplified formulae --- p.34 / Chapter 3.3.7 --- Orthogonal analysis of WZ-e and its simplified formulae on TEAC assay --- p.40 / Chapter 3.4 --- Discussion --- p.42 / Chapter Chapter 4 --- Antioxidant Activity of Aqueous Extracts of Simplified Formulae of Wu-zi-yan-zong-wan in vitro --- p.44 / Chapter 4.1 --- Introduction --- p.44 / Chapter 4.1.1 --- In vitro antioxidant --- p.44 / Chapter 4.1.2 --- Antioxidant effect of Catechins --- p.44 / Chapter 4.1.3 --- MTT assay --- p.45 / Chapter 4.1.4 --- Objectives --- p.46 / Chapter 4.2 --- Materials and methods --- p.47 / Chapter 4.2.1 --- Materials --- p.47 / Chapter 4.2.1.1 --- Cell Culture --- p.47 / Chapter 4.2.1.2 --- Reagents --- p.47 / Chapter 4.2.2 --- Methods --- p.47 / Chapter 4.2.2.1 --- Cell Culture --- p.47 / Chapter 4.2.2.2 --- MTT Cytotoxicity Assay --- p.48 / Chapter 4.2.3 --- Statistical analysis --- p.48 / Chapter 4.3 --- Results --- p.49 / Chapter 4.3.1 --- The effect of WZ-e formula on HepG2 cells --- p.49 / Chapter 4.3.2 --- The effect of hydrogen peroxide on HepG2 cells --- p.49 / Chapter 4.3.3 --- The effect of menadione on HepG2 cells --- p.52 / Chapter 4.3.4 --- The effect of catechin on HepG2 cells --- p.52 / Chapter 4.3.5 --- The effect of WZ-e and its simplified formulae against hydrogen peroxide-induced cytotoxicty on HepG2 cells --- p.55 / Chapter 4.3.6 --- The effect of WZ-e and its simplified formulae against menadione-induced cytotoxicity on HepG2 cells --- p.60 / Chapter 4.3.7 --- The effect of WZ-p on HepG2 cells --- p.65 / Chapter 4.3.8 --- The effect of WZ-p and its simplified formulae against hydrogen peroxide-induced cytotoxicity on HepG2 cells --- p.67 / Chapter 4.3.9 --- The effect of WZ-p and its simplified formulae against menadione-induced cytotoxicity on HepG2 cells --- p.72 / Chapter 4.4 --- Discussion --- p.77 / Chapter Chapter 5 --- Effect of Aqueous Extract of Wu-zi-yan-zong-wan on Menadione-induced Oxidative Damage in Mouse Liver --- p.79 / Chapter 5.1 --- Introduction --- p.79 / Chapter 5.2 --- Materials and methods --- p.81 / Chapter 5.2.1 --- Materials --- p.81 / Chapter 5.2.1.1 --- Animals --- p.81 / Chapter 5.2.1.2 --- Reagents --- p.81 / Chapter 5.2.1.3 --- Apparatus --- p.81 / Chapter 5.2.2 --- Methods --- p.82 / Chapter 5.2.2.1 --- Animal treatments --- p.82 / Chapter 5.2.2.2 --- Collection of samples --- p.82 / Chapter 5.2.2.3 --- Marker enzyme measurement (ALT) --- p.83 / Chapter 5.2.3 --- Statistical analysis --- p.83 / Chapter 5.3 --- Results --- p.84 / Chapter 5.3.1 --- Dose-dependent effect of WZ-e on menadione hepatotoxicity --- p.84 / Chapter 5.3.2 --- Dose-dependent effect of WZ-e on menadione hepatotoxicity as illustrated by histopathological observations --- p.86 / Chapter 5.3.3 --- Analyzing he effect of WZ-e and its simplified formulae on menadione-induced hepatotoxicity by Orthogonal Analysis89 --- p.89 / Chapter 5.4 --- Discussion --- p.91 / Conclusion --- p.93 / References --- p.95

Poon Wing-sem. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2005. / Includes bibliographical references (leaves 163-171). / Abstracts in English and Chinese. / ABSTRACT I-IV --- p.I-IV / ACKNOWLEDGMENTS V --- p.V / TABLE OF CONTENT --- p.VI-VIII / LIST OF FIGURES AND TABLES --- p.IX-XI / LIST OF ABBREVIATIONS --- p.XII / Chapter CHAPTER ONE --- LITERATURE REVIEW --- p.1 / Chapter 1.1 --- Rutaceae --- p.1 / Chapter 1.1.1 --- Introduction --- p.1 / Chapter 1.1.2 --- taxonomy of Rutaceae --- p.2 / Chapter 1.1.3 --- Controversial taxonomic issues --- p.4 / Chapter 1.1.3.1 --- Subfamilies Rutoideae and Toddalioideae --- p.4 / Chapter 1.1.3.2 --- "Euodia, Melicope and Tetradium" --- p.7 / Chapter 1.1.3.2.1 --- History --- p.7 / Chapter 1.1.3.2.2 --- Arguments based on morphology --- p.10 / Chapter 1.2 --- Molecular Approach --- p.12 / Chapter 1.2.1 --- Introduction to molecular systematics --- p.12 / Chapter 1.2.2 --- DNA sequence markers --- p.14 / Chapter 1.2.3 --- Applications --- p.18 / Chapter 1.3 --- Traditional Chinese Medicine (TCM) --- p.21 / Chapter 1.3.1 --- Introduction --- p.21 / Chapter 1.3.2 --- Fructus Evodiae --- p.22 / Chapter 1.3.3 --- Functional chemicals and pharmacological effects of Fructus Evodiae --- p.23 / Chapter 1.3.4 --- Problem in authentication --- p.25 / Chapter 1.4 --- Objectives --- p.27 / Chapter CHAPTER TWO --- METHODOLOGY AND MATERIALS --- p.29 / Chapter 2.1 --- Plant and Herb Materials --- p.29 / Chapter 2.2 --- DNA extraction --- p.44 / Chapter 2.2.1 --- Modified cetyltriethylammonium bromide (CTAB) extraction --- p.44 / Chapter 2.2.2 --- Kit extraction --- p.45 / Chapter 2.2.2.1 --- DNeasy® Plant MiniKit of Qiagen --- p.45 / Chapter 2.2.2.2 --- GenElute´ёØ Plant Genomic DNA Miniprep Kit of Sigma® --- p.46 / Chapter 2.3 --- Polymerase chain reaction (PCR) reaction --- p.47 / Chapter 2.4 --- DNA gel electrophoresis --- p.49 / Chapter 2.5 --- PCR product purification --- p.49 / Chapter 2.5.1 --- Rapid Gel Extraction System of Marligen Biosciences INC --- p.50 / Chapter 2.5.2 --- Gel-M´ёØ Gel Extraction System --- p.50 / Chapter 2.6 --- Ligation and transformation --- p.51 / Chapter 2.6.1 --- Ligation and transformation --- p.51 / Chapter 2.6.2 --- Cell culture --- p.52 / Chapter 2.6.3 --- Plasmid extraction --- p.52 / Chapter 2.7 --- Determination of DNA concentration --- p.54 / Chapter 2.8 --- Cycle Sequencing --- p.54 / Chapter 2.9 --- Sequence Analysis --- p.55 / Chapter 2.10 --- Materials --- p.56 / Chapter CHAPTER THREE --- MOLECULAR AUTHENTICATION OF FRUCTUSEVODIAE --- p.60 / Chapter 3.1 --- Results and data analysis --- p.60 / Chapter 3.1.1 --- Authentication based on ITS-1 region --- p.60 / Chapter 3.1.1.1 --- Phylogram study --- p.60 / Chapter 3.1.1.2 --- Sequence alignment --- p.65 / Chapter 3.1.1.3 --- ITS-1 region nucleotide differences significant in authentication of Fructus Evodiae --- p.71 / Chapter 3.1.1.4 --- Comparison of sequences --- p.74 / Chapter 3.1.2 --- Authentication based on ITS-2 region --- p.78 / Chapter 3.1.2.1 --- Phylogram study --- p.78 / Chapter 3.1.2.2 --- Sequence alignment --- p.82 / Chapter 3.1.2.3 --- ITS-2 region nucleotide differences significant inauthentication of Fructus Evodiae --- p.86 / Chapter 3.1.2.4 --- Comparison of sequences --- p.89 / Chapter 3.2 --- Discussion --- p.93 / Chapter 3.2.1 --- Molecular markers --- p.93 / Chapter CHAPTER FOUR --- PHYLOGENETIC STUDIES ON RUTACEAE --- p.96 / Chapter 4.1 --- Results and data analysis --- p.96 / Chapter 4.1.1 --- Chloroplast trnL intron region --- p.96 / Chapter 4.1.1.1 --- Sequence alignment --- p.96 / Chapter 4.1.1.2 --- Phylogenetic analysis --- p.107 / Chapter 4.1.2 --- Chloroplast trnL-F intergenic spacer region --- p.116 / Chapter 4.1.2.1 --- Sequence alignment --- p.116 / Chapter 4.1.2.2 --- Phylogenetic analysis --- p.126 / Chapter 4.1.3 --- Nuclear ITS-1 region --- p.132 / Chapter 4.1.3.1 --- Sequence alignment --- p.132 / Chapter 4.1.3.2 --- Phylogenetic analysis --- p.143 / Chapter 4.2 --- Discussion --- p.152 / Chapter 4.2.1 --- "Euodia, Melicope and Tetradium" --- p.152 / Chapter 4.2.2 --- Tetradium --- p.153 / Chapter 4.2.3 --- Tetradium and Phellodendron --- p.155 / Chapter 4.2.4 --- Zanthoxylum and Toddalia --- p.156 / Chapter 4.2.5 --- Rutoideae and Toddalioideae --- p.156 / Chapter 4.2.6 --- Tree constructing methods --- p.158 / Chapter CHAPTER FIVE --- CONCLUSION --- p.161 / REFERENCES --- p.163